Listed

Champions Oncology, Inc.: Form 10-K for the period ended Apr 30, 2012

Filed with the SEC on Jul 18, 2012 and accepted by EDGAR at Jul 18, 2012, 17:16 ET.

Share

Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2012-04-30. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Research and development12 months2011-05-01 to 2012-04-30$2.9mus-gaap:ResearchAndDevelopmentExpense
Operating income12 months2011-05-01 to 2012-04-30−$9.1mus-gaap:OperatingIncomeLoss
Income tax12 months2011-05-01 to 2012-04-30−$2.0kus-gaap:IncomeTaxExpenseBenefit
Net income12 months2011-05-01 to 2012-04-30−$8.7mus-gaap:NetIncomeLoss
Diluted EPS12 months2011-05-01 to 2012-04-30−$0.19us-gaap:EarningsPerShareBasicAndDiluted
Operating cash flow12 months2011-05-01 to 2012-04-30−$5.2mus-gaap:NetCashProvidedByUsedInOperatingActivities
Capital expenditure12 months2011-05-01 to 2012-04-30$519.0kus-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Share repurchases12 months2011-05-01 to 2012-04-30$0us-gaap:PaymentsForRepurchaseOfCommonStock
Cash and equivalentsAt period end2012-04-30$4.8mus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2012-04-30$5.5mus-gaap:AssetsCurrent
Total assetsAt period end2012-04-30$6.9mus-gaap:Assets
Current liabilitiesAt period end2012-04-30$3.5mus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2012-04-30$4.0mus-gaap:Liabilities
Shareholders' equityAt period end2012-04-30−$5.3mus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001144204-12-040031. Last ingested by Listed: Nov 10, 2026, 03:33 ET. Listed shows no prices and gives no investment advice.